# Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the Esophagus

> **NCT03785496** · PHASE2 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 44 (actual)

## Conditions studied

- Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment

## Interventions

- **DRUG:** PDR001

## Key facts

- **NCT ID:** NCT03785496
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-18
- **Primary completion:** 2022-01
- **Final completion:** 2024-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03785496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03785496, "Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the Esophagus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03785496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*